相关实验视频

Updated: Jun 26, 2025

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

成功的BK病毒特异性T细胞疗法在移植患者中,患者患有渐进式多焦点白内障

Abiu Sempere¹, Nerea Castillo², Francesc Rudilla³

¹Infectious Diseases Department. Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona. Spain.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

|May 11, 2024

概括

移植患者的渐进性多焦点白血脑病 (PML) 可以通过BKPyV病毒特异性T细胞疗法 (BKPyV-VST) 治疗. 这种创新方法在标准治疗失败时使患者稳定,显示PML管理的希望.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
病毒学病毒学
免疫学免疫学免疫学

背景情况:

渐进性多焦点白血脑病 (PML) 是固体器官移植受体的一种严重的机会性感染.
标准治疗包括降低免疫抑制,其有效性有限,并可能导致移植损失.

研究的目的:

报告第一个成功的第三方BKPyV-VST治疗PML的病例.
评估BKPyV-VST在标准治疗失败时管理PML的安全性和有效性.

主要方法:

一名64岁的男性脏移植接受者患有PML和神经状况恶化,接受了第三方BKPyV-VST.ST的治疗.
通过神经症状,脑脊液中的JC病毒 (JCV) DNA水平和T细胞反应来监测治疗疗效.

主要成果:

BKPyV-VST治疗导致了临床稳定,并显著降低了JCV-DNA水平.
与酶相关的免疫位点测定和TCRβ测序证实了JCV特异性T细胞反应的出现.
患者没有出现移植与宿主疾病或移植功能障碍.

结论:

第三方BKPyV-VST疗法是移植患者PML的可行和有效治疗方法.
这种方法为那些没有响应标准免疫抑制降低治疗的患者提供了潜在的替代方案.
在不损害移植完整性的情况下,BKPyV-VST疗法证明了安全性和有效性.

关键词:

这就是BK病毒.这就是JC病毒.接受脏的接受者在PML中,PML是PML.在VST疗法治疗中,

更多相关视频

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry

Published on: July 13, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.